Acadia Pharmaceuticals

ACAD

36.32

+0.49

+1.4%

After Hours:

35.98

-0.34

-0.9%

Please Login or Register

Login|Register FREE

Stock Price
Open: 35.85
Prev. Close: 35.83
Low/Hi: 35.33 - 36.54
52-Week: 20.68 - 41.20
Volumes
Equity: 1,323,702
90-Day Avg: 1,443,762
Option: 3,182
90-Day Avg: 1,742
Volatility
Todays Stock Vol: 26.5
20-Day (HV): 40.0
52-Week (HV): 48.6
30-Day IV: 49.9 -1.1
IV Pct Rank: 19% Subdued
Fundamental
Div. Yield: 0.0%
Earnings: 7-Nov (Est.)
P/E Ratio:
Market Cap: 4.4 B
Stock Type: Common
Sector: Healthcare
Industry: Biotechnology
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

ACAD Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Jun-2017 31-Mar-2017 31-Dec-2016 30-Sep-2016
Cash and Cash Equivalents 143,789 157,383 163,620 153,679
Short Term Investments 273,531 312,098 365,416 435,180
Investments - - - -
Accounts Receivable 12,378 9,519 7,140 5,224
Inventory 6,003 3,881 4,175 4,301
Loans - - - -
Prepaid Expenses 8,044 6,872 7,546 5,106
Net Property Plant and Equipment 3,296 3,471 3,081 3,159
Other Current Assets 0 0 0 0
Current Assets 443,745 489,753 547,897 603,490
Goodwill and Intangibles 6,277 6,646 7,015 7,385
Long Term Investments 0 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 456,315 503,013 561,153 617,384
Short Term Debt 0 0 0 0
Other Non-Current Assets 2,997 3,143 3,160 3,350
Accounts Payable 3,588 2,166 3,912 2,828
Accrued Liabilities and Other Payables 37,325 38,967 36,029 34,445
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 41,175 45,489 42,742 39,326
Other Current Liabilities 0 4,132 2,644 1,876
Accumulated Other Comprehensive Income -97 94 106 533
Preferred Stock 0 0 0 0
Current Liabilities 40,913 45,265 42,585 39,149
Common Stock 12 12 12 12
Other Non-Current Liabilities 262 224 157 177
Additional Paid-In Capital 1,504,778 1,479,530 1,452,272 1,432,796
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -1,089,553 -1,022,112 -933,979 -855,283
Total Equity 415,140 457,524 518,411 578,058
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Cash and Cash Equivalents 163,620 102,138 61,854 11,707
Short Term Investments 365,416 112,994 260,632 174,083
Investments - - - -
Accounts Receivable 7,140 1,638 964 0
Inventory 4,175 0 0 0
Loans - - - -
Prepaid Expenses 7,546 2,219 1,168 2,570
Net Property Plant and Equipment 3,081 2,203 553 579
Other Current Assets 0 0 0 0
Current Assets 547,897 218,989 324,618 188,360
Goodwill and Intangibles 7,015 0 0 0
Long Term Investments 0 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 561,153 221,896 325,458 189,118
Short Term Debt 0 0 0 0
Other Non-Current Assets 3,160 704 287 179
Accounts Payable 3,912 1,672 2,016 372
Accrued Liabilities and Other Payables 36,029 20,230 13,818 6,552
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 42,742 22,134 15,969 6,987
Other Current Liabilities 2,644 0 0 55
Accumulated Other Comprehensive Income 106 11 -9 48
Preferred Stock 0 0 0 0
Current Liabilities 42,585 21,902 15,834 6,979
Common Stock 12 10 10 9
Other Non-Current Liabilities 157 232 135 8
Additional Paid-In Capital 1,452,272 862,327 807,631 587,742
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -933,979 -662,586 -498,143 -405,668
Total Equity 518,411 199,762 309,489 182,131